Top news of the week: 28.08.2023.
Is Amgen Stock a Top Buy and Hold?
The biotech checks several important boxes for long-term shareholders.
New Commercial Operating Models Needed To Advance Life Sciences Tech
Biopharma companies are radically rethinking their commercial operating models to gain stronger business foundations. These new approaches, in turn, will help them to serve patients better ...
AI biotech company Genesis scores $200M to advance drug discovery
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
OCGN earnings call for the period ending June 30, 2023.
OCGN earnings call for the period ending June 30, 2023.
AI-discovered drugs will be for sale sooner than you think
It takes forever to get drugs on the market. AI could help speed up the process.
Researchers Explore the Promise and Peril of Using AI to Fight Cancer
Artificial intelligence brings both excitement and uncertainty for medicine. A healthy dose of human expertise is still recommended.
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?
This biotech stock has been on fire in 2023.
Strokes cost the Australian economy billions, but these biotech players could change that
More than 50,000 Australians are expected have a stroke for the first time in 2050, costing the economy billions in lost wellbeing and premature mortality.